加拿大重症监护试验组出版物作者多样性分析
该研究对加拿大重症监护试验组1994年至2020年10月发表的354篇同行评议论文进行定量内容分析,记录研究设计、作者数量及国家/国际合作,并针对第一作者、资深作者和每位共同作者记录性别、职业角色、医学学科、地理位置、学术阶段和可见少数族裔身份等多样性维度。共涉及4246人次作者、1205名唯一作者,平均每篇12名作者(标准差7.1)。全体作者中女性占37%、可见少数族裔占13.7%;第一作者和资深作者中女性分别占40%和34%,可见少数族裔分别占15%和10%。73%的论文列有多职业作者,54%列有多医学学科作者,45%列有早期职业教师,33%列有 trainees,67%列有可见少数族裔作者。作者来自不同省份和不同国家的论文分别占67%和40%。结论认为该试验组出版物作者在人口学和职业特征上具有多样性。
要点
- 全体4246人次作者中女性占37%,可见少数族裔占13.7%,提示作者队伍多样性仍有提升空间。
- 第一作者中女性占40%、资深作者中女性占34%;第一作者中可见少数族裔占15%、资深作者中占10%。
- 73%的论文列有多职业作者,54%列有多医学学科作者,体现跨专业协作较普遍。
- 45%的论文列有早期职业教师作者,33%列有 trainees 作者,67%列有可见少数族裔作者。
- 67%的论文有跨省作者,40%有跨国作者,显示一定地域协作广度。
适用人群与场景
- 加拿大重症监护试验组1994年至2020年10月发表的354篇同行评议论文及其4246人次作者(1205名唯一作者)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为对加拿大重症监护试验组同行评议文章的定量内容分析,共纳入354篇 eligible 出版物;74%(263/354)为观察性队列研究、随机试验和调查。
- 共记录4246人次作者,其中1205名为唯一作者;每篇论文平均作者数12(标准差7.1)。
- 全体作者中女性占37%,可见少数族裔占13.7%;第一作者中女性占40%、可见少数族裔占15%;资深作者中女性占34%、可见少数族裔占10%。
- 73%的论文列有多职业作者,54%列有多医学学科作者;45%列有早期职业教师,33%列有 trainees,67%列有可见少数族裔作者。
- 67%的论文列有来自不同省份的作者,40%列有来自不同国家的作者。
证据类型、等级与局限
- 证据类型为定量内容分析(观察性描述性研究),无干预、无对照、无随机化;原文未给出证据等级或推荐强度。
- 局限:原文未讨论局限性;设计本身为单中心协作组出版物描述性分析,仅反映该试验组作者特征,不能推断其他机构或人群。
对床旁实践的改变
- 原文未提及对急诊/ICU床旁实践的具体改变;结果仅描述加拿大重症监护试验组出版物作者多样性特征。
指南或共识出处
- 原文未提及指南或共识;来源为 Crit Care Med 发表的加拿大重症监护试验组出版物作者多样性分析。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Diverse perspectives improve the quality of scholarly initiatives. The demographic and professional diversity of scientists who contribute to critical care research and publications has not been described for the Canadian Critical Care Trials Group. Our objective was to describe the diversity of authors of publications from the Canadian Critical Care Trials Group.
DESIGN: We conducted a quantitative content analysis of peer-reviewed articles published on behalf of the Canadian Critical Care Trials Group.
SETTING: All peer-reviewed articles that were published on behalf of the Canadian Critical Care Trials Group between 1994 and October 2020.
SUBJECTS: For each publication, we recorded the study design, the number of authors, and national or international collaboration. For the lead author, the senior author, and each coauthor, we recorded the following facets of diversity: gender, professional role, medical discipline, geographic location, academic stage, and visible minority status.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We identified 354 eligible publications; 74% (263/354) reported observational cohort studies, randomized trials, and surveys. Of 4,246 authors, 1,205 were unique individuals. The mean (sd) number of authors per publication was 12 (7.1). Of all 4,246 authors, 37% were women, and 13.7% were members of a visible minority group. Of all lead or senior authors, 40% and 34% respectively were women; 15% of lead and 10% of senior authors were members of a visible minority group. Three-quarters (73%) of publications listed authors from more than one profession, and more than half (54%) listed authors from more than one medical discipline. Nearly half of publications (45%) listed authors who were early career faculty, 33% listed authors who were trainees, and 67% listed authors who were from visible minority groups. Authors from different provinces and from different countries were listed in 67% and 40% of publications, respectively.
CONCLUSIONS: Authors of Canadian Critical Care Trials Group publications are diverse with regard to demographic and professional characteristics.
参考来源
- Mehta S, Ahluwalia N, Heybati K, et al. Diversity of Authors of Publications From the Canadian Critical Care Trials Group. Crit Care Med. 2022. PMID: 34473658. doi:10.1097/CCM.0000000000005284
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。